Clinical Trial Detail

NCT ID NCT03228186
Title Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Docetaxel + MLN4924

Age Groups: senior adult

No variant requirements are available.